Grail CEO Bob Ragusa to Retire on June 1
Grail announced that Bob Ragusa will retire as CEO effective June 1. The board has appointed the company's President, Josh Ofman, to serve as Grail's CEO upon Ragusa's retirement. In addition, Ofman has been appointed to the Board of Directors, effective immediately. Ragusa will remain on the board until June 1 and plans to serve in a senior advisory role through March of 2027. Ofman joined Grail in 2019 and has served on numerous industry Boards, including BIO and the Precision Medicine Coalition. Before joining Grail, Ofman spent more than 15 years at Amgen, most recently as Senior Vice President, Global Value, Access and Policy. Earlier in his career, he was a faculty member in the Department of Medicine and Health Services Research at the UCLA School of Medicine and the Division of Digestive Diseases at Cedars-Sinai Medical Center.
